Skip to main content
Premium Trial:

Request an Annual Quote

Roche Discovery Chief Brown Will Head Cellzome

NEW YORK, Sept. 16-Cellzome has hired Roche discovery chief David Brown as president and chief executive officer, the company said today.


Brown will help guide the company as it progresses into drug development, former CEO Charles Cohen said in a statement.


He was previously global head of discovery at Roche, where he oversaw drug candidate development, in-licensing and acquisitions. Previously, at Pfizer, Brown was involved in developing Viagra.


Cohen will now chair Cellzome's supervisory board.


Cellzome's core research is in functional proteomics. The company plans to move into drug development by creating treatments for neurological disease, cancer, metabolic disorders and inflammation-related disease. It is based in Heidelberg, Germany.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.